Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial

Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new version entry appears in the study record history, indicating updates to the history page. There is no indication of changes to the study's core content, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2025-11-02T00:56:18.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Partial content expansion and status note.
    Difference
    13%
    Check dated 2025-10-04T12:15:14.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not alter core content or other critical info.
    Difference
    0.2%
    Check dated 2025-09-27T07:51:50.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Now the page displays 'Results Submitted' and Revision: v3.0.2, replacing 'No Results Posted' and Revision: v3.0.1. The 'Back to Top' element was removed.
    Difference
    0.9%
    Check dated 2025-09-13T01:43:43.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.6%
    Check dated 2025-09-05T19:55:25.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries.
    Difference
    42%
    Check dated 2025-08-29T18:41:00.000Z thumbnail image

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.